A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States
J Eeuwijk, G Ferreira, JP Yarzabal… - Infectious Diseases and …, 2024 - Springer
Introduction Clostridioides difficile infection (CDI) is a major public health threat. Up to 40%
of patients with CDI experience recurrent CDI (rCDI), which is associated with increased …
of patients with CDI experience recurrent CDI (rCDI), which is associated with increased …
[HTML][HTML] Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
YV Kiseleva, RV Maslennikov… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, leading
to fibrosis, cirrhosis and hepatocellular carcinoma and also associated with increased …
to fibrosis, cirrhosis and hepatocellular carcinoma and also associated with increased …
COVID-19 and Clostridioides difficile Coinfection Outcomes among Hospitalized Patients in the United States: An Insight from National Inpatient Database
The incidence of Clostridioides difficile infection (CDI) has been increasing compared to pre-
COVID-19 pandemic levels. The COVID-19 infection and CDI relationship can be affected by …
COVID-19 pandemic levels. The COVID-19 infection and CDI relationship can be affected by …
Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review
Y Liu, M Chen - Canadian Journal of Gastroenterology and …, 2022 - Wiley Online Library
Clostridium difficile is a Gram‐positive bacillus with fecal‐oral transmission and is currently
one of the most common nosocomial infections worldwide, which was renamed …
one of the most common nosocomial infections worldwide, which was renamed …
[HTML][HTML] Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
AH Patel, GN Pathak, A Chen, P Greenberg… - Annals of …, 2024 - Elsevier
Abstract Introduction and Objectives Non-alcoholic fatty liver disease (NAFLD) is the most
common liver disease worldwide and can progress to non-alcoholic steatohepatitis (NASH) …
common liver disease worldwide and can progress to non-alcoholic steatohepatitis (NASH) …